Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,773.20
(
0.00%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.20
(
-0.86%
)
Bitcoin
78,032.89
(
2.23%
)
News Focus
News Focus
Post# of 257433
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: DewDiligence post# 125229

Wednesday, 08/17/2011 1:19:28 PM

Wednesday, August 17, 2011 1:19:28 PM

Post# of 257433
With Zelboraf as a melanoma treatment, assuming Vismodegib gets approval for inoperable BCC (also going in operable BCC in earlier stages), Roche will have a nice niche in the skin cancer segment.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today